182 related articles for article (PubMed ID: 26995548)
1. Methods of Inducing Inflammatory Bowel Disease in Mice.
Bang B; Lichtenberger LM
Curr Protoc Pharmacol; 2016 Mar; 72():5.58.1-5.58.42. PubMed ID: 26995548
[TBL] [Abstract][Full Text] [Related]
2. Methods of inducing inflammatory bowel disease in mice.
Maxwell JR; Brown WA; Smith CL; Byrne FR; Viney JL
Curr Protoc Pharmacol; 2009 Dec; Chapter 5():Unit5.58. PubMed ID: 22294404
[TBL] [Abstract][Full Text] [Related]
3. Comparison of experimental mouse models of inflammatory bowel disease.
Oh SY; Cho KA; Kang JL; Kim KH; Woo SY
Int J Mol Med; 2014 Feb; 33(2):333-40. PubMed ID: 24285285
[TBL] [Abstract][Full Text] [Related]
4. Exploration of Inflammatory Bowel Disease in Mice: Chemically Induced Murine Models of Inflammatory Bowel Disease (IBD).
Gadaleta RM; Garcia-Irigoyen O; Moschetta A
Curr Protoc Mouse Biol; 2017 Mar; 7(1):13-28. PubMed ID: 28252200
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of colonic gene expression of three experimental colitis models mimicking inflammatory bowel disease.
te Velde AA; de Kort F; Sterrenburg E; Pronk I; ten Kate FJ; Hommes DW; van Deventer SJ
Inflamm Bowel Dis; 2007 Mar; 13(3):325-30. PubMed ID: 17206675
[TBL] [Abstract][Full Text] [Related]
6. Inhibitor of apoptosis-stimulating p53 protein protects against inflammatory bowel disease in mice models by inhibiting the nuclear factor kappa B signaling.
Qian K; Yuan L; Wang S; Kuang Y; Jin Q; Long D; Jiang Y; Zhao H; Liu K; Yao H
Clin Exp Immunol; 2021 Aug; 205(2):246-256. PubMed ID: 33942299
[TBL] [Abstract][Full Text] [Related]
7. CCL2 (pM levels) as a therapeutic agent in Inflammatory Bowel Disease models in mice.
Maharshak N; Hart G; Ron E; Zelman E; Sagiv A; Arber N; Brazowski E; Margalit R; Elinav E; Shachar I
Inflamm Bowel Dis; 2010 Sep; 16(9):1496-504. PubMed ID: 20222120
[TBL] [Abstract][Full Text] [Related]
8. Chronic Model of Inflammatory Bowel Disease in IL-10
Wang H; Vilches-Moure JG; Cherkaoui S; Tardy I; Alleaume C; Bettinger T; Lutz A; Paulmurugan R
Theranostics; 2019; 9(21):6031-6046. PubMed ID: 31534535
[No Abstract] [Full Text] [Related]
9. Comparison of two models of inflammatory bowel disease in rats.
Catana CS; Magdas C; Tabaran FA; Crăciun EC; Deak G; Magdaş VA; Cozma V; Gherman CM; Berindan-Neagoe I; Dumitraşcu DL
Adv Clin Exp Med; 2018 May; 27(5):599-607. PubMed ID: 29616750
[TBL] [Abstract][Full Text] [Related]
10. Imaging of intestinal lymphocyte homing by means of pinhole SPECT in a TNBS colitis mouse model.
Bennink RJ; van Montfrans C; de Jonge WJ; de Bruin K; van Deventer SJ; te Velde AA
Nucl Med Biol; 2004 Jan; 31(1):93-101. PubMed ID: 14741574
[TBL] [Abstract][Full Text] [Related]
11. Prevention and treatment of colitis with Lactococcus lactis secreting the immunomodulatory Yersinia LcrV protein.
Foligne B; Dessein R; Marceau M; Poiret S; Chamaillard M; Pot B; Simonet M; Daniel C
Gastroenterology; 2007 Sep; 133(3):862-74. PubMed ID: 17678918
[TBL] [Abstract][Full Text] [Related]
12. Divergent Effectiveness of Multispecies Probiotic Preparations on Intestinal Microbiota Structure Depends on Metabolic Properties.
Biagioli M; Capobianco D; Carino A; Marchianò S; Fiorucci C; Ricci P; Distrutti E; Fiorucci S
Nutrients; 2019 Feb; 11(2):. PubMed ID: 30717413
[TBL] [Abstract][Full Text] [Related]
13. PGRN protects against colitis progression in mice in an IL-10 and TNFR2 dependent manner.
Wei F; Zhang Y; Jian J; Mundra JJ; Tian Q; Lin J; Lafaille JJ; Tang W; Zhao W; Yu X; Liu CJ
Sci Rep; 2014 Nov; 4():7023. PubMed ID: 25387791
[TBL] [Abstract][Full Text] [Related]
14. Investigation of pulmonary involvement in inflammatory bowel disease in an experimental model of colitis.
Aydin B; Songur Y; Songur N; Aksu O; Senol A; Ciris IM; Sutcu R
Korean J Intern Med; 2016 Sep; 31(5):853-9. PubMed ID: 27539446
[TBL] [Abstract][Full Text] [Related]
15. The transcription factor IFN regulatory factor-4 controls experimental colitis in mice via T cell-derived IL-6.
Mudter J; Amoussina L; Schenk M; Yu J; Brüstle A; Weigmann B; Atreya R; Wirtz S; Becker C; Hoffman A; Atreya I; Biesterfeld S; Galle PR; Lehr HA; Rose-John S; Mueller C; Lohoff M; Neurath MF
J Clin Invest; 2008 Jul; 118(7):2415-26. PubMed ID: 18535667
[TBL] [Abstract][Full Text] [Related]
16. Lactococcus lactis carrying the pValac DNA expression vector coding for IL-10 reduces inflammation in a murine model of experimental colitis.
Zurita-Turk M; Del Carmen S; Santos AC; Pereira VB; Cara DC; Leclercq SY; de LeBlanc Ad; Azevedo V; Chatel JM; LeBlanc JG; Miyoshi A
BMC Biotechnol; 2014 Aug; 14():73. PubMed ID: 25106058
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory Bowel Disease: A Review of Pre-Clinical Murine Models of Human Disease.
Katsandegwaza B; Horsnell W; Smith K
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012618
[TBL] [Abstract][Full Text] [Related]
18. Sarcodon aspratus Extract Ameliorates Dextran Sulfate Sodium-Induced Colitis in Mouse Colon and Mesenteric Lymph Nodes.
Chung MY; Hwang JT; Kim JH; Shon DH; Kim HK
J Food Sci; 2016 May; 81(5):H1301-8. PubMed ID: 27074537
[TBL] [Abstract][Full Text] [Related]
19. A role for proteinase-activated receptor-1 in inflammatory bowel diseases.
Vergnolle N; Cellars L; Mencarelli A; Rizzo G; Swaminathan S; Beck P; Steinhoff M; Andrade-Gordon P; Bunnett NW; Hollenberg MD; Wallace JL; Cirino G; Fiorucci S
J Clin Invest; 2004 Nov; 114(10):1444-56. PubMed ID: 15545995
[TBL] [Abstract][Full Text] [Related]
20. Hapten-induced model of murine inflammatory bowel disease: mucosa immune responses and protection by tolerance.
Elson CO; Beagley KW; Sharmanov AT; Fujihashi K; Kiyono H; Tennyson GS; Cong Y; Black CA; Ridwan BW; McGhee JR
J Immunol; 1996 Sep; 157(5):2174-85. PubMed ID: 8757344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
